Inherited thrombophilias and adverse pregnancy outcome: Screening and management

Seminars in Perinatology

Volumn 29, Issue 3 SPEC. ISS., 2005, Pages 150-163

  Paidas, Michael J ^a   Ku, De Hui W ^b   Langhoff Roos, Jens ^c   Arkel, Yale S ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Bio Reference Laboratory   (United States)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Adverse pregnancy outcome; Pregnancy complications; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; DALTEPARIN; ENOXAPARIN; FATTY ACID BINDING PROTEIN; FOLIC ACID; FONDAPARINUX; HEPARIN; NADROPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTICOAGULATION; FETUS WASTAGE; GENE MUTATION; HELLP SYNDROME; HUMAN; HYPERHOMOCYSTEINEMIA; INHERITANCE; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SCREENING; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; THROMBOPHILIA;

EID: 21344443068     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2005.05.008     Document Type: Article

References (142)

1. M.J. Paidas, D.H. Ku, Y.S. Arkel Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome Clin Perinatol 31 2004 783 805
2. B. Dahlback Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene Haemostasis 24 1994 139 151
3. I.A. Greer Epidemiology, risk factors and prophylaxis of venous thromboembolism in obstetrics and gynecology Clin Obstet Gynecol 11 1997 403 430
4. I.A. Greer Thrombosis in pregnancy maternal and fetal issues Lancet 353 1999 1258 1265
5. P. Lindqvist, B. Dahlback, K. Marsal Thrombotic risk during pregnancy a population study Obstet Gynecol 94 1999 595 599
6. B.S. Andersen, F.H. Steffensen, H.T. Sorensen The cumulative incidence of venous thromboembolism during pregnancy and puerperium Acta Obstet Gynecol Scand 77 1998 170 173
7. M. Hellgren, M. Blomback Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium Gynecol Obstet Invest 12 1981 141 154
8. Y. Stirling, L. Woolf, W.R. North Haemostasis in normal pregnancy Thromb Haemost 52 1984 176 182
9. P.C. Comp, G.R. Thurnau, J. Welsh Functional and immunologic protein S levels are decreased during pregnancy Blood 68 1986 881 885
10. A.M. Cumming, R.C. Tait, S. Fildes Development of resistance to activated protein C during pregnancy Br J Haematol 90 1995 725 727
11. K.A. Bremme Hemostatic changes in pregnancy Baillieres Best Pract Res Clin Haematol 16 2003 153 168
12. D.H. Ku, Y.S. Arkel, M.P. Paidas Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies Thromb Haemost 90 2003 1074 1079
13. K. Bremme, E. Ostlund, I. Almqvist Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium Obstet Gynecol 80 1992 132 137
14. B. Dahlback Protein S and C4b-binding protein components involved in the regulation of the protein C anticoagulant pathway Thromb Haemost 66 1991 49 61
15. L.O. Mosnier, J.C.M. Meijers, B.N. Bouma The role of protein S in the activation of TAFI and regulation of fibrinolysis Thromb Haemost 86 2001 1035 1039
16. A.C. Dykes, I.D. Walker, A.D. McMahon A study of Protein S antigen levels in 3788 healthy volunteers influence of age, sex and hormone use, and estimate for prevalence of deficiency state Br J Haematol 113 2001 636
17. M. Sugimura, T. Kobayashi, N. Kanayama Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay Semin Thromb Hemost 25 1999 497 502
18. N.A. Prager, D.R. Abendschein, C.R. McKenzie Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots Circulation 92 1995 962 967
19. M.J. Paidas, D.W. Ku, M.J. Lee Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications J Thromb Haemost 3 2005 497 501
20. M. Paidas, D.W. Ku, Y. Arkel Normal pregnancy is associated with the development of Protein S and Protein Z antibodies, independent of PS and PZ level Am J Obstet Gynecol 191 2004 S491
21. X. Han, R. Fiehler, G.J. Broze Jr Characterization of the protein Z-dependent protease inhibitor Blood 96 2000 3049 3055
22. B. Kemkes-Matthes, K.J. Matthes Protein Z Seminars Thromb Hemost 5 2001 551 556
23. G.J. Broze Jr Protein Z-dependent regulation of coagulation Thromb Haemost 86 2001 8 13
24. G.J. Broze Jr Protein-Z and thrombosis Lancet 357 2001 933 934
25. X. Han, Z.F. Huang, R. Fiehler The protein Z-dependent protease inhibitor is a serpin Biochemistry 38 1999 11073 11078
26. M. Yurdakok, B. Gurakan, E. Ozbag Plasma protein Z levels in healthy newborn infants Am J Hematol 48 1995 206 207
27. J.P. Miletich, G.J. Broze Jr Human plasma protein Z antigen range in normal subjects and effect of warfarin therapy Blood 69 1987 1580 1586
28. B. Kemkes-Matthes, M. Nees, G. Kuhnel Protein Z influences the prothrombotic phenotype in factor V Leiden patients Thromb Res 106 2002 183 185
29. M.D. McColl, A. Deans, P. Maclean Plasma protein Z deficiency is common in women with antiphospholipid antibodies Br J Haematol 120 2003 913 914
30. B. Steffano, R. Forastiero, M. Martinuzzo Low plasma protein Z levels in patients with antiphospholipid antibodies Blood Coagul Fibrinolysis 12 2001 411 412
31. G. Gamba, G. Bertolino, N. Montani Bleeding tendency of unknown origin and protein Z levels Thromb Res 90 1998 291 295
32. W.A. Wuillemin, F. Demarmels Biasiutti, H.P. Mattle Frequency of PZ deficiency in patients with ischemic stroke Lancet 358 2001 840 841
33. J.C. Gris, I. Quere, H. Dechaud High frequency of protein Z deficiency in patients with unexplained early fetal loss Blood 99 2002 2606 2608
34. J.C. Gris, E. Mercier, I.I. Quere Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder Blood 103 2004 3695 3699
35. J.C. Gris, C. Amadio, E. Mercier Anti- protein Z antibodies in women with pathologic pregnancies Blood 101 2003 4850 4852
36. C.J. Lockwood Inherited thrombophilias in pregnant patients detection and treatment paradigm Obstet Gynecol 99 2002 333 341
37. J. Girling, M. de Swiet Inherited thrombophilia and pregnancy Curr Opin Obstet Gynecol 10 1998 135 144
38. F.E. Preston, F.R. Rosendaal, I.D. Walker Increased fetal loss in women with heritable thrombophilia Lancet 348 1996 913 916
39. M.J. Kupferminc, A. Eldor, N. Steinman Increased frequency of genetic thrombophilia in women with complications of pregnancy N Engl J Med 340 1999 9
40. Z. Alfirevic How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review Eur J Obstet Gynecol Reprod Biol 101 2002 6 14
41. D. Dahlback, J. Stenflo A natural anticoagulant pathway proteins C, S, C4b-binding protein and thrombomodulin A.L. Bloom C.D. Forbes D.P. Thomas G.D. Tuddenham Haemostasis and Thrombosis (ed 3) 1994 Churchill Livingstone New York, NY 671 698
42. E. Rey, S.R. Kahn, M. David Thrombophilic disorders and fetal loss a meta- analysis Lancet 361 2003 901 908
43. P.M. Ridker, J.P. Miletich, C.H. Hennekens Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening J Am Med Assoc 277 1997 1305 1307
44. C.J. Lockwood Inherited thrombophilias in pregnant patients Prenat Neonat Med 6 2001 3 14
45. J. Voorberg, J. Roeise, R. Koopman Association of idiopathic venous thromboembolism with single point-mutation at Arg 506 of factor V Lancet 343 1994 1535 1536
46. S.R. Poort A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
47. A. Gerhardt, R. Eberhard Scharf, M. Wilhelm Beckmann Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium N Engl J Med 342 2000 374 380
48. L.T. Hunt, M.O. Dayhoff A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha-1 proteinase inhibitor Biochem Biophys Res Comm 95 1980 864 871
49. P. Gettins, D.P. Patson, M. Schapira Structure and mechanism of action of serpins Hematol Oncol Clin North Am 6 1992 1393 1418
50. P.A. Andreasen, B. Georg, L.R. Lund Plasminogen activator inhibitors hormonally regulated serpins Mol Cell Endocrinol 68 1990 1 19
51. E.K.O. Kruithof, C. Tran-Thang, A. Gudinchet Fibrinolysis in pregnancy a study of plasminogen activator inhibitors Blood 69 1987 460 466
52. J. Gilabert, A. Estelles, J. Aznar Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia Thromb Haemost 63 1990 361 366
53. B. Astedt, I. Lecander, T. Ny The placental type plasminogen activator inhibitor, PAI-2 Fibrinolysis 1 1987 203 208
54. C.W. Francis Plasminogen activator inhibitor-1 levels and polymorphisms Arch Pathol Lab Med 126 2002 1401 1404
55. L. Hefler, S. Jirecek, K. Heim Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death a multicenter study J Soc Gynecol Invest 11 2004 42 44
56. H. Weiler, B.H. Isermann Thrombomodulin J Thromb Haemost 1 2003 1515 1524
57. M.J. Paidas, D.H. Ku, M.J. Lee Patients with thrombophilia and subsequent adverse pregnancy outcomes have a decreased first trimester response to thrombomodulin in an activated partial thromboplastin time (APTT) system J Thromb Haemost 2 2004 840 841
58. Z.J. Foka, A.F. Lambropoulos, H. Saravelos Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages Hum Reprod 15 2000 458 462
59. H. Roque, M.J. Paidas, E.F. Funai Maternal thrombophilias are not associated with early pregnancy loss Thromb Haemost 91 2004 290 295
60. R.P. Murphy, C. Donoghue, R.J. Nallen Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy Arterioscler Thromb Vasc Biol 20 2000 266 270
61. W.L. Nelen, H.J. Blom, E.A. Steegers Hyperhomocysteinemia and recurrent early pregnancy loss a meta-analysis Fertil Steril 74 2000 1196
62. C.V. Ananth Placental abruption and perinatal mortality in the United States Am J Epidemiol 153 2001 332 337
63. D.J. Barker Fetal nutrition and cardiovascular disease in adult life Lancet 341 1993 938 941
64. D.J. Barker Fetal nutrition and cardiovascular disease in later life Br Med Bull 53 1997 96 108
65. I.M. Bernstein Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network Am J Obstet Gynecol 182 2000 198 206
66. S.J. Ventura, W.D. Mosher, S.C. Curtin Trends in pregnancy rates for the United States, 1976-1997 an update Natl Vital Stat Rep 49 2001 1 9
67. A. Samueloff Recurrent stillbirth. Significance and characteristics J Reprod Med 38 1993 883 886
68. J.C. Gris Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent the Nimes Obstetricians and Haematologists Study5 (NOHA5) Thromb Haemost 81 1999 891 899
69. I. Martinelli Mutations in coagulation factors in women with unexplained late fetal loss N Engl J Med 343 2000 1015 1018
70. I. Martinelli Recurrent late fetal death in women with and without thrombophilia Thromb Haemost 87 2002 358 359
71. S. Rasmussen, L.M. Irgens, K. Dalaker The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence Br J Obstet Gynaecol 104 1997 1292 1295
72. C.V. Ananth, J.C. Smulian, A.M. Vintzileos Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy a meta-analysis of observational studies Obstet Gynecol 93 1999 622 628
73. C.V. Ananth, D.A. Savitz, M.A. Williams Placental abruption and its association with hypertension and prolonged rupture of membranes a methodologic review and meta-analysis Obstet Gynecol 88 1996 309 318
74. S. Rasmussen, L.M. Irgens, S. Albrechtsen Women with a history of placental abruption when in a subsequent pregnancy should special surveillance for a recurrent placental abruption be initiated? Acta Obstet Gynecol Scand 80 2001 708 712
75. M. Furuhashi, O. Kurauchi, N. Suganuma Pregnancy following placental abruption Arch Gynecol Obstet 267 2002 11 13
76. E. Sheiner, I. Shoham-Vardi, A. Hadar Incidence, obstetric risk factors and pregnancy outcome of preterm placental abruption a retrospective analysis J Matern Fetal Neonatal Med 11 2002 34 39
77. A. Many, R. Elad, Y. Yaron Third trimester unexplained intrauterine fetal death is associated with inherited thrombophilia Obstet Gynecol 99 2002 684 687
78. B.M. Sibai, B. Mercer, C. Sarinoglu Severe preeclampsia in the second trimester recurrence risk and long-term prognosis Am J Obstet Gynecol 165 1991 1408 1412
79. B.M. Sibai, A. el-Nazer, A. Gonzalez-Ruiz Severe preeclampsia-eclampsia in young primigravid women subsequent pregnancy outcome and remote prognosis Am J Obstet Gynecol 155 1986 1011 1016
80. C.A. Sullivan, E.F. Magann, K.G. Perry Jr The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations Am J Obstet Gynecol 171 1994 940 943
81. M.D. Hnat, B.M. Sibai, S. Caritis National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine-Units Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas Am J Obstet Gynecol 186 2002 422 426
82. L. Chesley Hypertensive Disorders in Pregnancy 1978 Appleton New York, NY 421 443
83. D.M. Campbell, I. MacGillivray, R. Carr-Hill Pre-eclampsia in second pregnancy Br J Obstet Gynaecol 92 1985 131 140
84. B.M. Sibai, M.K. Ramadan, R.S. Chari Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) subsequent pregnancy outcome and long-term prognosis Am J Obstet Gynecol 172 1995 125 129
85. J. Zhang Risks of hypertensive disorders in the second pregnancy Obstet Gynecol 95 2000 S77
86. R. Resnik Intrauterine growth restriction Obstet Gynecol 99 2002 490 496
87. S. Rasmussen, I.M. Lorentz, S. Albrechtsen Predicting preeclampsia in the second pregnancy from low birth weight in the first pregnancy Obstet Gynecol 96 2000 696 700
88. R.A. Odegard, L.J. Vatten, S.T. Nilsen Risk factors and clinical manifestations of preeclampsia Br J Obstet Gynecol 107 2000 1410 1416
89. P.J. Surkan Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth N Engl J Med 350 2004 777 785
90. J. Zhang Small-for-gestational-age infants and risk of fetal death in subsequent pregnancies N Engl J Med 350 2004 754 756
91. S. Uzan, M. Beaufils Prevention of fetal growth retardation with low-dose aspirin findings of the Epreda trial Lancet 337 1991 1427 1431
92. L. Regan, R. Rai Epidemiology and the medical causes of miscarriage Baillaires Best Pract Res Clin Obstet Gynaecol 14 2000 839 854
93. A.E. Sullivan, R.M. Silver, D.Y. LaCoursiere Recurrent fetal aneuploidy and recurrent miscarriage Obstet Gynecol 104 2004 784 788
94. G. Kovalevsky, C.R. Gracia, J.A. Berlin Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss Arch Intern Med 164 2004 558 563
95. J.L. Kujovich Thrombophilia and pregnancy complications Am J Obstet Gynecol 191 2004 412 424
96. Langhoff-Roos J, Paidas MJ, Ku DH,, et al. Inherited thrombophilias and early pregnancy loss, in Mor G (ed): Immunology of Pregnancy. Eurekah.com 2005 and Springer Science + Business Media (in press)
97. M.F. Reznikoff-Etievan, V. Cayol, B. Carbonne Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage Br J Obstet Gynaecol 108 2001 1251 1254
98. F. Dawood Acquired activated protein C resistance may be a risk factor for recurrent fetal loss Fertil Steril 80 2003 649 650
99. N. Riyazi, M. Leeda, J.I. de Vries Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction a preliminary study Eur J Obstet Gynecol Reprod Biol 80 1998 49 54
100. B. Brenner Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin Thromb Haemost 83 2000 693 697
101. O. Ogueh Outcome of pregnancy in women with hereditary thrombophilia Int J Gynaecol Obstet 74 2001 247 253
102. M. Kupferminc, G. Fait, A. Many Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia Hypertens Pregnancy 20 2001 35 44
103. E. Grandone Preventing adverse obstetric outcomes in women with genetic thrombophilia Fertil Steril 78 2002 371 375
104. M.J. Kupferminc, H. Peri, E. Zwang High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss Acta Obstet Gynecol Scand 79 2000 963 967
105. G.A. Dekker Underlying disorders associated with severe early-onset preeclampsia Am J Obstet Gynecol 173 1995 1042 1048
106. D. Dizon-Townson The factor V Leiden mutation may predispose women to severe preeclampsia Am J Obstet Gynecol 175 1996 902 905
107. B. Nagy Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women Clin Genet 53 1998 478 481
108. T. Krauss Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome Obstet Gynecol 92 1998 457 460
109. E.C. VanPampus High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia Am J Obstet Gynecol 180 1999 1146 1150
110. C.J. De Groot, K.W. Bloemenkamp, E.J. Duvekot Preeclampsia and genetic risk factors for thrombosis a case-control study Am J Obstet Gynecol 181 1999 975 980
111. G.F. vonTempelhoff Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome Thromb Res 100 2000 363 365
112. E.R. Morrison Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension results from a large population-based study and systematic review Thromb Haemost 87 2002 779 785
113. C.V. Ananth, J.C. Smulian, A.M. Vintzileos Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy a meta-analysis of observational studies Obstet Gynecol 93 1999 622 628
114. A. Addis Fetal effects of cocaine an updated meta-analysis Reprod Toxicol 15 2001 341 369
115. J.I. deVries Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies Br J Obstet Gynaecol 104 1997 1248 1254
116. C. Infante-Rivard Absence of association of thrombophilia polymorphisms with intrauterine growth restriction N Engl J Med 347 2002 19 25
117. M. Paidas, D.H. Ku, E. Triche Does heparin therapy improve pregnancy outcome in patients with thrombophilias? J Thromb Haemost 2 2004 1194 1195
118. B. Brenner, R. Hoffman, H. Carp Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss the LIVE-ENOX study J Thromb Haemost 3 2005 227 229
119. M.C. Walker Heparin for pregnant women with acquired or inherited thrombophilias Cochrane Database Syst Rev 2 2003 CD003580
120. S.M. Bates, I.A. Greer, J. Hirsh Use of antithrombotic agents during pregnancy the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 3 2004 627S 644S
121. B.J. Sanson, A.W. Lensing, M.H. Prins Safety of low-molecular-weight heparin in pregnancy a systematic review Thromb Haemost 81 1999 668 672
122. J. Lepercq, J. Conard, A. Borel-Derlon Venous thromboembolism during pregnancy a retrospective study of enoxaparin safety in 624 pregnancies Br J Obstet Gynaecol 108 2001 1134 1140
123. F. Lagrange, C. Vergnes, J.L. Brun Absence of placental transfer of pentasaccharide in the dually perfused human cotyledon in vitro Thromb Haemost 87 2002 831 835
124. T.E. Warkentin Heparin induced thrombocytopenia V.C. Broudy J.T. Prchal G.J. Tricot Hematology 2003 2003 American Society of Hematology Washington, DC 503 509
125. G.M. Stirrat Recurrent miscarriage Lancet 336 1990 673 675
126. M.J. Kupferminc, G. Fait, A. Many Severe preeclampsia. High frequency of genetic thrombophilic mutations Obstet Gynecol 96 2000 45 49
127. J. Rigo Maternal and neonatal outcome of preeclamptic pregnancies the potential roles of factor V Leiden mutations and 5, 10 methylenetrahydrofolate reductase Hypertens Pregnancy 19 2000 163 172
128. Y.J. Kim, R.A. Williamson, J.C. Murray Genetic susceptibility to preeclampsia roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation Am J Obstet Gynecol 184 2001 1211 1217
129. J. Livingston Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia Am J Obstet Gynecol 185 2001 153 157
130. L. Currie Is there an increased maternal-infant prevalence of Factor V Leiden in association with severe pre-eclampsia? Br J Obstet Gynaecol 109 2002 191 196
131. Benedetto Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome Acta Obstet Gynecol 81 2002 1095 1100
132. D. Schlembach Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction Clin Sci 105 2003 279 285
133. J.I. deVries Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies Br J Obstet Gynaecol 104 1997 1248 1254
134. Z. Wiener-Megnagi, I. Ben-Shlomo, Y. Goldberg Resistance to activated protein C and the leiden mutation high prevalence in patients with abruptio placentae Am J Obstet Gynecol 179 1998 1565 1567
135. F. Faccinetti Thrombophilic mutations are a main risk factor for placental abruption Haemotologica 88 2003 785 788
136. I. Martinelli Familial thrombophilia and the occurrence of fetal growth restriction Haematologica 86 2001 428 431
137. M.J. Kupferminc Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia Br J Obstet Gynaecol 109 2002 1373 1376
138. E. Verspyck Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants Br J Obstet Gynaecol 109 2002 28 33
139. D. Dizon-Townson The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis Am J Obstet Gynecol 176 1997 883 886
140. A. Tal A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure Hum Reprod 4 1999 1624 1627
141. P.G. Lindqvist, B. Dahlback Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy Thromb Haemost 84 2000 140 141
142. A. Alonso Acquired and inherited thrombophilia in women with unexplained fetal losses Am J Obstet Gynecol 187 2002 1337 1342